TrendingNews.today

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

As of Mar 25

Health1 sourcesNeutral

Newly approved head and neck cancer treatment improves care for first time in more than 20 years

The Pharmaceutical Journal from the Royal Pharmaceutical Society

The Pharmaceutical Journal

via The Pharmaceutical Journal

March 24, 2026 | 3:55 PM UTCUpdated 2h ago

Share Read original

Read the full article at The Pharmaceutical Journal →

Newly approved head and neck cancer treatment improves care for first time in more than 20 years

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

The Pharmaceutical Journal

Comments

0 comments

Be respectful and constructive.

Loading comments...

Steam Spring Sale 2026 includes 20 of 2025's best games

Nigeria’s TB response faces funding crisis – Coordinator

Related Articles

Shena Carty, a beloved champion for the needy, dies in Florida crash

Shena Carty, a beloved champion for the needy, dies in Florida crash

Unknown-1h ago-1 sources

Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial

Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial

Pr Newswire-12h ago-1 sources

Perth childcare fined $25,000 for leaving child on bus on 39-degree day

Watoday-12h ago-1 sources